DOW-ISONIAZID Drug Patent Profile
✉ Email this page to a colleague
When do Dow-isoniazid patents expire, and what generic alternatives are available?
Dow-isoniazid is a drug marketed by Dow Pharm and is included in one NDA.
The generic ingredient in DOW-ISONIAZID is isoniazid. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dow-isoniazid
A generic version of DOW-ISONIAZID was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
Summary for DOW-ISONIAZID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 154 |
Clinical Trials: | 219 |
Patent Applications: | 4,295 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DOW-ISONIAZID at DailyMed |
Recent Clinical Trials for DOW-ISONIAZID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University College, London | Phase 2 |
Radboud University Medical Center | Phase 2 |
University of Stellenbosch | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DOW-ISONIAZID
US Patents and Regulatory Information for DOW-ISONIAZID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dow Pharm | DOW-ISONIAZID | isoniazid | TABLET;ORAL | 080330-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |